X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs BIOCON LTD - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER BIOCON LTD PFIZER/
BIOCON LTD
 
P/E (TTM) x 31.0 76.7 40.5% View Chart
P/BV x 4.9 7.2 68.4% View Chart
Dividend Yield % 0.7 0.2 381.9%  

Financials

 PFIZER   BIOCON LTD
EQUITY SHARE DATA
    PFIZER
Mar-16
BIOCON LTD
Mar-17
PFIZER/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs2,7241,162 234.4%   
Low Rs1,611483 333.9%   
Sales per share (Unadj.) Rs440.9194.6 226.6%  
Earnings per share (Unadj.) Rs48.734.4 141.5%  
Cash flow per share (Unadj.) Rs75.848.3 157.0%  
Dividends per share (Unadj.) Rs15.001.00 1,500.0%  
Dividend yield (eoy) %0.70.1 569.0%  
Book value per share (Unadj.) Rs462.9241.9 191.4%  
Shares outstanding (eoy) m45.75200.00 22.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.94.2 116.3%   
Avg P/E ratio x44.523.9 186.3%  
P/CF ratio (eoy) x28.617.0 167.9%  
Price / Book Value ratio x4.73.4 137.7%  
Dividend payout %30.82.9 1,059.8%   
Avg Mkt Cap Rs m99,163164,440 60.3%   
No. of employees `0002.99.2 31.3%   
Total wages/salary Rs m2,7587,470 36.9%   
Avg. sales/employee Rs Th6,981.74,213.9 165.7%   
Avg. wages/employee Rs Th954.5809.0 118.0%   
Avg. net profit/employee Rs Th771.1745.2 103.5%   
INCOME DATA
Net Sales Rs m20,17038,911 51.8%  
Other income Rs m8571,571 54.6%   
Total revenues Rs m21,02840,482 51.9%   
Gross profit Rs m4,3109,795 44.0%  
Depreciation Rs m1,2392,772 44.7%   
Interest Rs m5260 2.0%   
Profit before tax Rs m3,9238,334 47.1%   
Minority Interest Rs m0163 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,7941,616 111.0%   
Profit after tax Rs m2,2286,881 32.4%  
Gross profit margin %21.425.2 84.9%  
Effective tax rate %45.719.4 235.9%   
Net profit margin %11.017.7 62.5%  
BALANCE SHEET DATA
Current assets Rs m16,29940,477 40.3%   
Current liabilities Rs m7,59416,783 45.2%   
Net working cap to sales %43.260.9 70.9%  
Current ratio x2.12.4 89.0%  
Inventory Days Days6560 109.5%  
Debtors Days Days2683 31.1%  
Net fixed assets Rs m8,62245,073 19.1%   
Share capital Rs m4581,000 45.8%   
"Free" reserves Rs m20,72247,377 43.7%   
Net worth Rs m21,18048,377 43.8%   
Long term debt Rs m2521,082 0.1%   
Total assets Rs m29,13793,942 31.0%  
Interest coverage x755.533.1 2,285.6%   
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.70.4 167.1%   
Return on assets %7.77.6 100.8%  
Return on equity %10.514.2 73.9%  
Return on capital %19.012.6 150.6%  
Exports to sales %0.10-   
Imports to sales %17.50-   
Exports (fob) Rs m12NA-   
Imports (cif) Rs m3,526NA-   
Fx inflow Rs m5212,988 0.4%   
Fx outflow Rs m1407,899 1.8%   
Net fx Rs m-885,089 -1.7%   
CASH FLOW
From Operations Rs m3,4366,400 53.7%  
From Investments Rs m-6,991-4,985 140.2%  
From Financial Activity Rs m-619-1,775 34.9%  
Net Cashflow Rs m-4,174-473 882.3%  

Share Holding

Indian Promoters % 0.0 40.4 -  
Foreign collaborators % 63.9 20.6 310.2%  
Indian inst/Mut Fund % 7.5 8.4 89.3%  
FIIs % 4.9 10.7 45.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 19.9 119.1%  
Shareholders   85,207 109,995 77.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DIVIS LABORATORIES  WOCKHARDT LTD.  VENUS REMEDIES  PLETHICO PHARMA  GLENMARK PHARMA  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Firm; Software & FMCG Stocks Gain(Closing)

Indian share markets finished the trading session well above the dotted line, snapping a three-day falling streak amid firm Asian markets.

Related Views on News

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Feb 21, 2018 (Close)

TRACK PFIZER

PFIZER - JUBILANT LIFE SCIENCES COMPARISON

COMPARE PFIZER WITH

MARKET STATS